Tacrine Pregnancy and Breastfeeding Warnings
Brand names: Cognex
Tacrine Pregnancy Warnings
Tacrine has been assigned to pregnancy category C by the FDA. Animal studies have not yet been conducted. Tacrine has been used with suxamethonium historically to reduce postoperative respiratory depression in women undergoing Cesarean section. In one study, tacrine was recovered in the urine of neonates whose mothers received suxamethonium and tacrine. No serious effects were reported. There are no controlled data in human pregnancy or data concerning the use of tacrine during embryogenesis. Tacrine should only be given in pregnancy when benefit outweighs risk.
Tacrine Breastfeeding Warnings
There are no data on the excretion of tacrine into human milk.
See also
References for pregnancy information
- Speirs I (1966) "The use of tacrine and suxamethonium in anaesthesia for caesarean section." Br J Anaesth, 38, p. 394-400
- (2001) "Product Information. Cognex (tacrine)." Parke-Davis
References for breastfeeding information
- (2001) "Product Information. Cognex (tacrine)." Parke-Davis
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
